Four months after GSK settled a key case in California over its heartburn medication Zantac, AstraZeneca is following suit, agreeing to resolve personal injury claims over its heartburn drugs Nexium ...
LONDON (Reuters) - Britain's AstraZeneca said on Tuesday it was aware South Korea's Hanmi Pharmaceutical had launched a competitor to its top selling stomach-acid drug Nexium in the United States. A U ...
LONDON (Reuters) - AstraZeneca's drive to extend the life of its blockbuster acid reflux drug Nexium through new uses was set back on Tuesday after U.S. regulators delayed approval of a drug combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback